Penile cancer, though rare, has a high mortality rate due to delayed diagnosis and lymph node metastasis. ILND is indicated for intermediate- or high-risk penile cancer, with specific criteria guiding ...

As I was getting up from my visit with Mrs. Gregory, her right hand went to the base of her neck. Dr. Smith, do you think this little lump is anything?” Though doing her best to portray calm, she ...

Mouse research shows tattoo pigments move into lymph nodes within minutes and persist for months Ink triggered immune-cell death, chronic inflammation and weakened response to an mRNA COVID shot ...

Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically removing them along with tumors may weaken treatment, while preserving them ...

Papillary thyroid cancer (PTC) generally has a good prognosis, with 5-year relative survival rates of 99% for regional cancer that has spread to the lymph nodes. PTC is the most common type of thyroid ...

In a trial, selected patients with early non-small cell lung cancer did not benefit from mediastinal lymph node dissection (LND). Mediastinal LND resulted in longer surgeries, increased bleeding, and ...

Lymph nodes are a key part of the human immune system, whose primary function is to combat infections. The effectiveness of vaccines is based on their ability to trigger events in lymph nodes that ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...

ABSTRACT: Introduction: Vulva cancer is an uncommon disease. It represents about 3% to 5% of gynecologic cancers worldwide, but its incidence is increasing with age and Human Papilloma Virus (HPV) and ...

Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...